在帕金森病中,无细胞DNA和线粒体
Małgorzata Wojtkowska1, Franciszek Ambrosius2
1Institute of Molecular Biology and Biotechnology, Faculty of Biology, Adam Mickiewicz University, 61-614 Poznan, Poland.
International journal of molecular sciences
|December 11, 2025
概括
无细胞DNA (cfDNA) 显示出作为帕金森病 (PD) 的非侵入性生物标志物具有前途. 研究探讨了cfDNA的研究.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 生物化学 生物化学
背景情况:
- 帕金森病 (PD) 是一种进展性神经退行性疾病,其特点是神经元的损失,由于其异质性,造成诊断挑战.
- 可靠的生物标志物对于准确的PD诊断和个性化的治疗策略至关重要.
- 无细胞DNA (cfDNA),包括线粒体 (cf-mtDNA) 和核 (cf-ntDNA) 片段,释放到体液中,并显示出作为非侵入性生物标记物的潜力.
研究的目的:
- 提供关于cfDNA起源及其在PD中的作用的当前知识的全面审查.
- 要突出线粒体,cf-mtDNA,线粒体质量控制和神经炎症在PD相关的cfDNA生物发生中的参与.
- 探索cfDNA作为PD在血清,血和脑脊液 (CSF) 中的诊断和监测生物标志物的潜力.
主要方法:
- 文献综述对cfDNA的现有研究进行了整理.
- 对cfDNA生物发生路径的分析,包括线粒体的作用和神经炎症.
- 对各种与PD相关的生物流体中cfDNA特征 (类型,序列分析) 的检查.
主要成果:
- cfDNA通过亡,亡,NETosis或活性分泌物释放.
- 线粒体和cf-mtDNA在PD病变发生和cfDNA释放中起着重要的作用.
- 在血清,血和脑脊液中cfDNA分析显示了PD诊断和监测的潜力.
结论:
- cfDNA代表了帕金森病的一个有希望的非侵入性生物标志物候选者.
- 了解cfDNA生物发生,特别是线粒体参与,是其在PD中的应用的关键.
- 对cfDNA分析的进一步研究可以提高PD患者的诊断精度和治疗指导.
关键词:
帕金森病是帕金森氏症的一种疾病.没有细胞的DNA (cfDNA)没有细胞的线粒体DNA (cf-mtDNA)没有细胞的核DNA (cf-ntDNA)大脑脊髓液中的脑脊液.线粒体中的线粒体.线粒细胞衰变 (mitophagy) 是一种神经衰变的过程.神经炎症是一种神经炎症.血等离子体是什么?血液中的血清是血清.更多相关视频
15:09The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
Published on: October 3, 2012
17.3K
06:57Author Spotlight: Fluorescence-Based Quantification of Mitochondrial Membrane Potential and Superoxide Levels Using Live Imaging in HeLa Cells
Published on: May 12, 2023
9.0K
相关概念视频
Animal Mitochondrial Genetics
8.9K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
8.9K
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
Parkinson's Disease: Treatment
940
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
940
Mitochondria
19.5K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
19.5K
EPS and iPS Cells in Disease Research
3.3K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.3K
